Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
Drug Discovery
Intellectual Property
R&D Pipeline
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.


Nyloxin // Chronic Pain Relief

Nyloxin is an over-the-counter (OTC) pain reliever for the treatmentment of moderate to severe chronic pain. It is available as both an oral spray and as a topical gel. Nyloxin is specifically formulated to treat back pain, neck pain, headaches, joint pain, migraines, arthritis pain, pain from repetitive stress and neuralgia.

For additional information about Nyloxin, visit

Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.


Recent News
September 09, 2015
Nutra Pharma To Present at Upcoming Investment Conference

September 08, 2015
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration for the Treatment of Juvenile Multiple Sclerosis

July 15, 2015
Nutra Pharma Announces the Submission of Their First Orphan Drug Application to the US Food and Drug Administration (FDA)

Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
Facebook   Twitter
Privacy Policy Code of Ethics